REMUS PHARMACEUTICALS L Financial Ratios
REMUS · Healthcare · Current price ₹734.1
P/E ratio
23.4x
P/B ratio
2.5x
ROE
12.2%
ROCE
17.0%
Debt / Equity
0.08
Dividend yield
0.1%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 23.4x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.5x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 12.2% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 17.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.08 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with REMUS PHARMACEUTICALS L's latest numbers.
REMUS PHARMACEUTICALS L profitability
REMUS PHARMACEUTICALS L generates a return on equity of 12.2% and a return on capital employed of 17.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.08 and a P/E of 23.4x, REMUS PHARMACEUTICALS L is conservatively financed. Our overall business-quality score for the company is 5.4 / 10.
Understand the ratios
More on REMUS PHARMACEUTICALS L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.